Dr. Greg Peterson represents and advises clients on a wide variety of intellectual property issues. Greg specializes in domestic and international biotechnology, chemical, pharmaceutical and medical device patent prosecution. Dr Peterson has filed and prosecuted over 100 patent applications in diverse technological areas, including nucleic acid-based diagnostics, immunology and potential treatments for diverse types of cancer, including glioma, breast, melanoma, prostate and liver cancer, arrhythmia, diabetes, Alzheimer’s diseases, Huntington’s disease, arthritis, influenza virus and immune system dysregulation.
Greg's practice also includes all phase of patent and technology licensing, client counseling, intellectual property portfolio maintenance and strategic planning. Dr. Peterson has counseled companies in all phases of technology development and assisted the companies in implementing patent and business strategies to enhance technological market position and execute company strategy. In addition, Greg regularly advises clients in trademark prosecution and FDA approval of branded pharmaceutical products.
After graduating from the University of Alabama with a degree in Microbiology, Greg attended the graduate program at the University of Alabama at Birmingham receiving his Ph.D. in Biochemistry and Molecular Genetics. During his time at UAB, Greg became interested in the molecular basis of oncogenesis and signal transduction. During his 4th year, Greg received the prestigious Betram-Marx award for Outstanding Cancer Research for his work on the effects of naturally occurring estrogenic compounds in breast cancer. Dr. Peterson graduated from the University of Virginia School of Law where he was active in the Virginia Journal of Law and Technology.